{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT00702741",
      "OrgStudyIdInfo": {
        "OrgStudyId": "551"
      },
      "Organization": {
        "OrgFullName": "Mesoblast, Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy",
      "OfficialTitle": "A Long-Term Follow-up Study of Chondrogen - Adult Human Stem Cells Delivered by Intra-articular Injection Following Meniscectomy in Subjects 18-60 Years"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2022",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "June 2008"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2011",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 2011",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "June 19, 2008",
      "StudyFirstSubmitQCDate": "June 19, 2008",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 20, 2008",
        "StudyFirstPostDateType": "Estimate"
      },
      "DispFirstSubmitDate": "December 23, 2021",
      "DispFirstSubmitQCDate": "January 7, 2022",
      "DispFirstPostDateStruct": {
        "DispFirstPostDate": "January 11, 2022",
        "DispFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 7, 2022",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 11, 2022",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Mesoblast International Sàrl",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The objective of the present study is to establish the long-term safety of an intra-articular injection of human mesenchymal stem cells (hMSCs) (Chondrogen).",
      "DetailedDescription": "The long-term safety of human mesenchymal stem cells (hMSCs) (Chondrogen) has not yet been established. This 3-year follow-up study will provide additional data to gain understanding of the safety of the investigational agent. This study is designed to determine the safety of a single intra-articular injection of 50 million donor-derived hMSCs or 150 million donor-derived hMSCs in suspension with commercial sodium hyaluronan compared to an injection of vehicle (diluted hyaluronan) alone. The injections were performed under the initial study, Protocol No. 550."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Recovery Following Partial Medial Meniscectomy"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Knee",
          "Meniscus",
          "Meniscectomy",
          "Mesenchymal Stem Cells",
          "MSCs",
          "Adult Human Stem Cells",
          "Osiris",
          "Chondrogen"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Quadruple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "55",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "A",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Chondrogen (low dose)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Chondrogen"
              ]
            }
          },
          {
            "ArmGroupLabel": "B",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Chondrogen (high dose)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Chondrogen"
              ]
            }
          },
          {
            "ArmGroupLabel": "C",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Hyaluronan",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Placebo"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Chondrogen",
            "InterventionDescription": "Intra-articular injection of ex vivo cultured adult human mesenchymal stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "A"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Chondrogen",
            "InterventionDescription": "Intra-articular injection of ex vivo cultured adult human mesenchymal stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "B"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Placebo",
            "InterventionDescription": "Intra-articular injection of Hyaluronan",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "C"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Comparison of treatment adverse event rates",
            "PrimaryOutcomeTimeFrame": "Through 3 years"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Concomitant Medications",
            "SecondaryOutcomeTimeFrame": "Through 3 years"
          },
          {
            "SecondaryOutcomeMeasure": "Visual Analog Scale",
            "SecondaryOutcomeTimeFrame": "Through 3 years"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSubject must have received an injection in Protocol No. 550\nSubject must have completed the 6-month and final 2-year visit in Protocol No. 550\nSubject must provide written informed consent for entry into the extension study\nSubject must provide authorization for use and disclosure of protected health information for entry into the extension study",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "60 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University of Southern California Keck School of Medicine",
            "LocationCity": "Los Angeles",
            "LocationState": "California",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "OrthoIndy",
            "LocationCity": "Indianapolis",
            "LocationState": "Indiana",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "TRIA Orthopaedic Center",
            "LocationCity": "Bloomington",
            "LocationState": "Minnesota",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Unlimited Research",
            "LocationCity": "San Antonio",
            "LocationState": "Texas",
            "LocationCountry": "United States"
          }
        ]
      }
    }
  },
  "ResultsSection": {
    "MoreInfoModule": {}
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M9030",
            "InterventionBrowseLeafName": "Hyaluronic Acid",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M186752",
            "InterventionBrowseLeafName": "Remestemcel-l",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          },
          {
            "InterventionBrowseBranchAbbrev": "Infe",
            "InterventionBrowseBranchName": "Anti-Infective Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "Infl",
            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
          }
        ]
      }
    }
  }
}